(NASDAQ: DRIO)
Company Information
DarioHealth is a global digital therapeutics solution leader revolutionizing the way people manage their chronic conditions. The company offers Dario Tools, which are devices that integrate with applications on a user’s smartphone; DarioEngage, a population health management platform; and the Dario Loop, an AI-driven journey engine.
Built for and around the user, Dario has created individualized solutions that combine best practices in digital technologies, analytics, hardware, and personal coaching that gently instruct, encourage, and inspire users to self-manage their health day to day. It also sells device-specific disposables test strip cartridges, lancets, and Dario Blood Glucose Monitoring System; and Dario Smart Diabetes Management Solution, which includes tools to help diabetic patients manage their disease. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is based in New York, New York.
Insights
DarioHealth Corp. a leader in the global digital therapeutics (DTx) market, announced today that a large Northeast U.S. supermarket chain (the “Employer”) selected Dario to help improve the cardiometabolic health of its employees beginning in the first quarter of 2023, marking the Company reaching 100 enterprise contracts signed. This milestone achievement validates the Company’s strategic position as a leading provider of integrated digital chronic condition management solutions in the employer and payer markets.
Northeast supermarket chain will deploy Dario’s cardiometabolic suite in 2023.
DarioHealth Corp. a leader in the global digital therapeutics (DTx) market, announced today that a large Northeast U.S. supermarket chain (the “Employer”) selected Dario to help improve the cardiometabolic health of its employees beginning in the first quarter of 2023, marking the Company reaching 100 enterprise contracts signed. This milestone achievement validates the Company’s strategic position as a leading provider of integrated digital chronic condition management solutions in the employer and payer markets.
Digital healthcare is resulting not only in better health outcomes, but lower costs for the national health-care sector. Dario’s user-centric multi-chronic condition platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health providing a turn-key one vendor solution for payors.
The day has come. Today, October 14th, DarioHealth announced an agreement with one of the largest national health plans. Under the agreement, Dario will offer its behavioral health solution to the Plan’s self-insured employer customers serving millions of members.
DarioHealth is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health.
DarioHealth acquires behavioral health digital platform wayForward to complement its best-in-class suite of digital therapeutics for chronic conditions.
CEO, Erez Raphael, noted progress in the Company’s transformation to a software as a service (SaaS) business model with high margin recurring revenues; transition to a Business-to-Business-to-Consumer (B2B2C) focused digital therapeutics providers with larger member pools and lower customer acquisition costs; and the ongoing expansion of their product offering to manage multiple chronic conditions.
English
Français
Español